Access to anti-retroviral drugs, female in Kuwait
Kuwait: Access to anti-retroviral drugs, female was 58.0% in 2024. ▲ Rising
Access to anti-retroviral drugs, female in Kuwait, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Kuwait is 58.0%, measured in 2024. That is the highest value across all 25 years on record.
The figure is up 13.7% on the previous year and up 87.1% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Kuwait peaked at 58.0% in 2024 and was at its lowest, 18.0%, in 2000.
Kuwait ranks 105th of 141 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Access to anti-retroviral drugs, female in Kuwait, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 18.0% | — |
| 2001 | 20.0% | +11.1% |
| 2002 | 25.0% | +25.0% |
| 2003 | 25.0% | +0.0% |
| 2004 | 26.0% | +4.0% |
| 2005 | 29.0% | +11.5% |
| 2006 | 27.0% | -6.9% |
| 2007 | 25.0% | -7.4% |
| 2008 | 24.0% | -4.0% |
| 2009 | 23.0% | -4.2% |
| 2010 | 22.0% | -4.3% |
| 2011 | 27.0% | +22.7% |
| 2012 | 27.0% | +0.0% |
| 2013 | 30.0% | +11.1% |
| 2014 | 31.0% | +3.3% |
| 2015 | 31.0% | +0.0% |
| 2016 | 37.0% | +19.4% |
| 2017 | 39.0% | +5.4% |
| 2018 | 43.0% | +10.3% |
| 2019 | 46.0% | +7.0% |
| 2020 | 49.0% | +6.5% |
| 2021 | 52.0% | +6.1% |
| 2022 | 48.0% | -7.7% |
| 2023 | 51.0% | +6.2% |
| 2024 | 58.0% | +13.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 24.2% | 18.0% | 29.0% | 10 |
| 2010s | 33.3% | 22.0% | 46.0% | 10 |
| 2020s | 51.6% | 48.0% | 58.0% | 5 |
Countries ranked near Kuwait
- 103 Kazakhstan 60.0% compare
- 103 Kyrgyzstan 60.0% compare
- 105 Bulgaria 58.0% compare
- 105 Mexico 58.0% compare
- 108 Greece 57.0% compare
- 108 Timor-Leste 57.0% compare
More gender data for Kuwait
- Child population (UN estimates and projections) 914.66 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.3397 % change on previous year (2030)
- Population 4,410 (2030)
- Working-age population (UN estimates and projections) 4,410 (2030)
- Population (UN estimates and projections), annual growth rate 1.03 % change on previous year (2030)
- Age population, age 00, female, interpolated 24,181 (2025)
- Age population, age 00, male, interpolated 25,253 (2025)
- Age population, age 01, female, interpolated 25,948 (2025)
- Age population, age 01, male, interpolated 26,723 (2025)
- Age population, age 02, female, interpolated 26,893 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Kuwait?
- Access to anti-retroviral drugs, female in Kuwait was 58.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Kuwait?
- The highest recorded value was 58.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Kuwait?
- The lowest recorded value was 18.0% in 2000.
- How does Kuwait rank for access to anti-retroviral drugs, female?
- Kuwait ranks 105th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Kuwait?
- Over the last ten years it is up 87.1%. The long-run trend across the full record is rising.
- Where does this Kuwait data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.